Some genetic polymorphisms of TNF-α have been found to be associated with susceptibility to Hepatocellular carcinoma. We investigated TNF-α 308(G/A), TNF-α

238(G/A), TNF-α 863(C/A), TNF-α 857(C/T) and TNF-α 1031(T/C) polymorphisms for association with HCC in Korean. Methods: Patients with HCC diagnosed at CHA Bundang Medical Y-27632 datasheet Center from June 1996 to August 2008 were enrolled. The association of TNF-α polymorphisms with HCC was analyzed in 157 HCC patients and 201 controls by the polymerase chain reaction-restriction fragment length polymorphism. Results: Any TNF-α polymorphisms was not significantly associated with HCC patients. Genotype combinations of TNF-α polymorphisms: TNF-α –1031/-857/-238 TT/CC/GA(Adjusted Roxadustat research buy Odds ratio (AOR)=18.849,

95%CI = 2.203-161.246, P =0.007), TNF-α -1031/-308/-238 TT/GG/GA(AOR = 26.956, 95%CI = 3.071–236.584, P =0.003) TT/GA/GG(AOR = 2.712, 95%CI = 1.085–6.778, P =0.033), TNF-α -863/-308/-238 CC/GA/GG(AOR = 2.533, 95%CI = 1.007–6.371, P =0.048) CA/GG/GA(AOR = 4.242, 95%CI = 1.243–14.473, P =0.021), TNF-α -1031/-238 TT/GA(AOR = 21.576, 95%CI = 2.581–180.394, P =0.005), TNF-α -863/-238 CA/GA(AOR = 3.669, 95%CI = 1.098 – 12.253, P =0.035). TNF-α -308/-238 GA/GG(AOR = 2.283, 95%CI = 1.078–4.836, P =0.031) GA+AA/GG(AOR = 2.150, 95%CI = 1.041–4.441, P =0.039) were significantly increased in HCC patients. Haplotype: TCCGA(TNF-α –1031/-836/-857/-308/-238, AOR = 25.824, 95%CI = 1.491 – 447.223, P =0.0005), TCGA(TNF-α –1031/-857/-308/-238, AOR = 12.059, 95%CI = 2.747 – 52.950, P < 0.0001), TCA(TNF-α –1031/857/-238, AOR = 10.696, 上海皓元 95%CI = 2.428 – 47.110, P =0.0001), TGA(TNF-α –1031/-308/-238, AOR = 7.556, 95%CI = 2.173 – 26.280, P =0.0002), TA(TNF-α –1031/-238, AOR = 10.865, 95%CI = 2.473 – 47.740, P =0.0001) were found to significantly increase in HCC patients. TNF-α -1031 CC genotype had better survival

in OKUDA stage III (AOR = 5.795, 95%CI = 1.145–29.323, P =0.035) than TT genotype. Conclusion: Although a single TNF-α polymorphism was not related to HCC in this study, some genotype combinations and haplotypes of TNF-α show relation to the risk of HCC. And HCC patients of TNF-α -1031 CC genotype may have good prognosis than TT genotype in OKUDA stage III. Key Word(s): 1. HCC; 2. TNF-α; Presenting Author: QIAN BI Additional Authors: SHANHONG TANG, RUI FAN, NEERAJ AGARWAL, YONGQUAN SHI, TOMOO IWAKUMA, JIE DING Corresponding Author: TOMOO IWAKUMA, JIE DING Affiliations: Xijing Hospital of Digestive Diseases & State Key Laboratory of Cancer Biology, Fourth Military Medical University; University of Kansas Medical Center Objective: Hepatocellular carcinoma (HCC) is a rising cause of cancer-related death in the United States with a 5-year survival rate below 12%. The leading cause of this poor prognosis is metastatic spread.